NEW YORK, July 28 (Reuters) - Mylan Inc said it won U.S. approval for the first generic version of Sciele Pharma Inc's blood-pressure drug Sular, and would ship its product immediately, sending Sciele ...
Sciele Pharma has received FDA approval for all four dosage strengths of its new Sular (nisoldipine) formulation. The new Sular formulation uses SkyePharma’s Geomatrix technology to provide a lower ...
ATLANTA Sciele Pharma has received approval from the Food and Drug Administration for all four dosage strengths of the formulation for the company’s drug Sular. Sular is used for the treatment of ...
SkyePharma has pocketed a million dollars and stands to earn another $4 million in milestone payments for the successful development of a new, controlled-release form of the anti-hypertensive Sular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results